Brain Health in 2030: Navigating Neuroplasticity & the Digital Health Market

By SharpBrains | January 23, 2024

Brain Health in 2030: Nav­i­gat­ing Neu­ro­plas­tic­i­ty & the Dig­i­tal Health Mar­ket from Sharp­Brains Keynote deliv­ered by Álvaro Fer­nán­dez, CEO of Sharp­Brains, dur­ing cor­po­rate retreat. Key mes­sage: Our very human brains and minds are the most sophis­ti­cat­ed tech­nol­o­gy at our dis­pos­al, so we should invest more time learn­ing about how they work and har­ness­ing neu­ro­­plas­tic­i­­ty-based methods…

Read More

Emerging applications of transcranial Direct Current Stimulation (tDCS): e‑sports skills training, cognitive enhancement in older adults

By SharpBrains | April 16, 2021

10 Min­utes of Elec­tri­cal Stim­u­la­tion Dur­ing Gam­ing Helps Improve e‑Sports Skills (Tech­nol­o­gy Net­works): Researchers at Lero, the Sci­ence Foun­da­tion Ire­land Research Cen­tre for Soft­ware and Uni­ver­si­ty of Lim­er­ick (UL), have found video gamers can sig­nif­i­cant­ly improve their esport skills by train­ing for just 10 min­utes a day. The research team at Lero’s Esports Sci­ence Research Lab…

Read More

Studies identify key ethical concerns raised by invasive and non-invasive neurotechnologies

By SharpBrains | November 23, 2020

Stud­ies out­line key eth­i­cal ques­tions sur­round­ing brain-com­put­er inter­face tech (NCSU release): Brain-com­put­er inter­face (BCI) tech­nolo­gies are no longer hypo­thet­i­cal, yet there are fun­da­men­tal aspects of the tech­nol­o­gy that remain unad­dressed by both ethi­cists and pol­i­­cy-mak­ers. Two new papers address these issues by out­lin­ing the out­stand­ing eth­i­cal issues, offer­ing guid­ance for address­ing those issues, and offering…

Read More

Study: Over-the-counter “brain enhancement” supplements in the US found both to a) contain multiple unapproved drugs and b) lack some ingredients listed on the label

By SharpBrains | October 20, 2020

Study: Your Brain Sup­ple­ments Could Con­tain Dan­ger­ous, Ille­gal Ingre­di­ents (Being Patient): Brain sup­ple­ments that claim to boost cog­ni­tive func­tion are increas­ing­ly pop­u­lar, grow­ing from a $4 bil­lion indus­try of about 4,000 unique prod­ucts to a $40 bil­lion indus­try with as many as 80,000 dif­fer­ent prod­ucts on the market. 

Read More

Study: Some “brain-boosting” supplements sold in the US contain not-approved drugs at supratherapeutic doses, exposing users to unknown side effects

By SharpBrains | December 2, 2019

___ Some brain-boost­­ing sup­ple­ments con­tain an unap­proved drug that could harm users, study warns (STAT news): “Promis­ing to lift brain fog or improve mem­o­ry, brain-boost­­ing sup­ple­ments have joined sex­u­al-enhance­­ment and weight-loss reme­dies in the light­ly reg­u­lat­ed world of dietary sup­ple­ments. These prod­ucts may be sold legal­ly with broad-brush come-ons like these, as long as they don’t…

Read More

How to address privacy, ethical and regulatory issues: Examples in cognitive enhancement, depression and ADHD

By SharpBrains | July 23, 2019

? How to address pri­va­cy, eth­i­cal and reg­u­la­to­ry issues: Exam­ples in cog­ni­tive enhance­ment, depres­sion and ADHD from Sharp­Brains We hope you enjoy this slid­edeck sup­port­ing a great ses­sion at the 2019 Sharp­Brains Vir­tu­al Sum­mit: The Future of Brain Health (March 7–9th).  Full record­ings are avail­able for pur­chase here. 1–2.30pm. How to address pri­va­cy, eth­i­cal and reg­u­la­to­ry issues: Examples…

Read More